BioSpace News Archive

Varian (NYSE: VAR) today announced its third quarter fiscal year 2020 earnings release date.

Awarded 1 Million € in non-dilutive Deep Tech funding, an initiative which supports advanced biotechnologies that are highly differentiated with significant commercialization potential

The first WHO enlisted global clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to combat COVID-19 has started in Abu Dhabi, inspired by the UAE Leadership’s commitment to overcome the pandemic through a global collaborative effort.

A burgeoning pharmaceutical industry hard-pressed to find treatments and cures for various chronic and other ailments has given rise to the concept of cell banking.

Gout is a chronic inflammatory disease characterized by swollen joints, pain, heat, redness, and joint stiffness.

X-Vax Technology, Inc. (X-VAX ® ), a biotechnology company developing vaccines based on a new approach that mediates the killing of infected cells, today announced the appointment of Isaac Blech as Vice Chairman of the company’s board of directors. As a co-founder of X-VAX, Mr. Blech previously served on the company’s Board until De

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology, oncology, critical care and endoscopy announced today that it will release its financial results for the quarter ended June 30, 2020, after the close of the stock market on Wednesday, July 29, 2020. Merit will hold its investor conference call (conference ID6997109) on the same day (Wedn

Facial Coverings Proven Safe Way to Help Mitigate Infection Risk and Slow Down Global Spread

Epion Health has been selected by Modern Healthcare as one of the 2020 Best Places to Work in Healthcare.

Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘ Company ’’) , a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its unaudited revenue for the second quarter of 2020 as well as for the first half of 2020. Revenue for the second quarter of 2020 (unaudited) In K€